Ingen internetforbindelse — viser den gemte version af siden.

Orion Oyj B

FIEUR
← Til Screeneren

Orion Oyj B (LSE:0M2O) — Drug Manufacturers - General. Antal børser, hvor selskabets aktier handles: 3. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
orionpharma.com
Sektor
Healthcare · Drug Manufacturers - General
Hovedkontor
Espo, Finland
Administrerende Direktør
Liisa Hurme
Ansatte
4 000
Børsnoteret Siden
07.11.2007 (LSE:0M2O)
Udestående Aktier
108.99 mio.
Free Float
123.49 mio.
Markedsværdi
11.42 mia. EUR
Insidere
2.63%
Institutionelle Investorer
45.48%
Udbetalingsgrad
41.3%
FCF
380 mio. EUR
Udbetaling / FCF
64%
Gæld
133 mio. EUR
0.3 år FCF
Udbyttestreak
21 år
Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 30.06.2026 (selskabets seneste rapport).
Beskrivelse

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Quetiapine products for antipsychotic; Trexan for rheumatoid arthritis and cancer; Easyhaler product portfolio for asthma and COPD; and Dexdor, Precedex, and Dexmedetomidine products for human use. The company also provides Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells drugs and products manufactured by other companies. Additionally, the company provides self-care products, including non-prescription medicines, cosmetics, dietary supplements, vitamins, and skincare products. It also offers its products online. The company has a licensing agreement with Tenax Therapeutics, Inc. to develop oral levosimendan (TNX-103) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF); and Bayer for the development and commercialisation of darolutamide Nubeqa. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.

annonce

Børser og Tickere

BørsTickerValutaPrisType
HE Nasdaq HelsinkiORNBV primærEUR80.8 -0.12%almindelige aktier
LSE London Stock Exchange0M2O IOBEUR45.86 +0.00%almindelige aktier
US USA StocksORINF OTCUSD92.05 +0.00%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Næste ex-dato: 2026-10-20 · 0.9 EUR (US:ORINF)
Pr. År, US:ORINF: ≈1.8 EUR (1 udb.)
Pr. År, HE:ORNBV: 0.9 EUR (1 udb.)

Orion Oyj B (ORINF) udbetaler udbytte to gange om året. Pr. År (12 måneder op til og med den senest annoncerede betaling): 1.8 EUR pr. Aktie (betalinger: 1). Den næste ex-udbyttedato er 20.10.2026: 0.9 EUR pr. Aktie, betalt den 27.10.2026. Uafbrudt udbyttehistorik: 21 år.

Ex-DatoUdbetalingBeløb%TypeTicker
2026-10-20 annonceret2026-10-270.9000 EUR1.1/2.2 %halvårligUS:ORINF
2026-03-252026-04-020.9000 EUR1.3/2.6 %halvårligHE:ORNBV
2025-10-152025-10-230.8200 EUR1.2/2.4 %halvårligHE:ORNBV
2025-04-042025-04-140.8200 EUR1.5/2.9 %halvårligHE:ORNBV
2024-10-152024-10-230.8100 EUR1.7/3.4 %halvårligHE:ORNBV
2024-03-212024-04-030.8100 EUR2.3/2.3 %årligHE:ORNBV
2023-03-23—1.6000 EUR3.7/3.7 %årligHE:ORNBV
2022-03-24—1.5000 EUR3.5/3.5 %årligHE:ORNBV

Største Ejere

EjerAndelAktierRapportdato
BlackRock, Inc.≈6.43%7.07 mio.2025-04-24
VANGUARD STAR FUNDS-Vang…1.42%1.56 mio.2026-07-31
VANGUARD TAX-MANAGED FUN…0.95%1.04 mio.2026-06-30
iShares Trust-iShares Co…0.75%825 3442026-08-31
DFA INVESTMENT TRUST CO-…0.55%600 7792026-07-31
DFA INVESTMENT DIMENSION…0.45%497 9172026-07-31
Fidelity Concord Street…0.39%426 2452026-07-31
iShares Trust-iShares MS…0.35%379 6642026-08-31
SPDR-EUROPE-SSgA SPDR ET…0.34%374 2452026-07-31
VANGUARD Intl Eqy. INDEX…0.23%254 0972026-07-31
VANGUARD Intl Eqy. INDEX…0.23%253 8582026-07-31
Pacer Advisors, Inc.0%4852026-06-30